Gene: ANKRD36
Official Full Name: ankyrin repeat domain 36provided by HGNC
Gene Summary: Predicted to enable ion channel inhibitor activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19836 | ANKRD36 Knockout cell line (HeLa) | Human | ANKRD36 | 1:3~1:6 | Negative | Online Inquiry |
KO19837 | ANKRD36 Knockout cell line (HCT 116) | Human | ANKRD36 | 1:2~1:4 | Negative | Online Inquiry |
KO19838 | ANKRD36 Knockout cell line (HEK293) | Human | ANKRD36 | 1:3~1:6 | Negative | Online Inquiry |
KO19839 | ANKRD36 Knockout cell line (A549) | Human | ANKRD36 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD36 Gene Knockout Cell Lines are specifically engineered cellular models designed to investigate the functional role of the ANKRD36 gene in various biological processes. These knockout cell lines have been developed through precise gene-editing technologies, such as CRISPR-Cas9, which enable the efficient disruption of the ANKRD36 gene, leading to a complete loss of its function. This allows for the study of gene-related pathways, cellular responses, and potential phenotypic alterations that arise from the absence of ANKRD36.
The primary mechanism of action involves the targeted removal of the ANKRD36 gene, which is implicated in cellular proliferation, differentiation, and critical signaling pathways. By utilizing these knockout models, researchers can elucidate the gene’s roles in health and disease, particularly in studies related to cancer progression, immune response, and developmental biology.
The scientific importance of ANKRD36 Gene Knockout Cell Lines extends to both research and clinical applications. They can serve as invaluable tools for identifying therapeutic targets, understanding genetic dysfunctions, and validating novel drug compounds. In a clinical context, these models contribute to personalized medicine approaches by enabling the assessment of how specific genetic alterations influence disease phenotypes and treatment responses.
One of the unique advantages of our ANKRD36 Gene Knockout Cell Lines is the rigorous quality control and validation processes they undergo, ensuring high specificity and reproducibility in experiments. Unlike other available models, our cell lines are meticulously characterized, providing essential insights into gene function while minimizing experimental variability. This focus on quality positions our product as a superior choice for researchers in both academia and industry.
For researchers and clinicians striving to advance their understanding of gene function and develop innovative therapies, ANKRD36 Gene Knockout Cell Lines offer a valuable resource. These models empower users to conduct robust experiments that translate into novel scientific discoveries.
With a proven track record in creating high-quality biological products, our company is dedicated to supporting the research community with cutting-edge tools like the ANKRD36 Gene Knockout Cell Lines, reinforcing our commitment to scientific advancement and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.